Synthesis, Structure–Activity Relationship Studies, and ADMET Properties of 3‐Aminocyclohex‐2‐en‐1‐ones as Chemokine Receptor 2 (CXCR2) Antagonists

doi:10.1002/cmdc.201800027

Paper

Synthesis, Structure–Activity Relationship Studies, and ADMET Properties of 3‐Aminocyclohex‐2‐en‐1‐ones as Chemokine Receptor 2 (CXCR2) Antagonists

Published May 8, 2018 · Weiyang Dai, Wenmin Chen, B. Debnath

ChemMedChem

Q1 SJR score

7

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Herein we describe the synthesis and structure–activity relationships of 3‐aminocyclohex‐2‐en‐1‐one derivatives as novel chemokine receptor 2 (CXCR2) antagonists. Thirteen out of 44 derivatives were found to inhibit CXCR2 downstream signaling in a Tango assay specific for CXCR2, with IC50 values less than 10 μm. In silico ADMET prediction suggests that all active compounds possess drug‐like properties. None of these compounds show significant cytotoxicity, suggesting their potential application in inflammatory mediated diseases. A structure–activity relationship (SAR) map has been generated to gain better understanding of their binding mechanism to guide further optimization of these new CXCR2 antagonists.

In Vitro Study

Study Snapshot

3aminocyclohex2en1one derivatives show potential as novel CXCR2 antagonists with drug-like properties and no significant cytotoxicity, suggesting potential applications in inflammatory diseases.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Synthesis, Structure–Activity Relationship Studies, and ADMET Properties of 3‐Aminocyclohex‐2‐en‐1‐ones as Chemokine Receptor 2 (CXCR2) Antagonists

Sign up to use Study Snapshot

References

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases

The CXCL8-CXCR1/2 axis plays a crucial role in inflammatory diseases and cancer progression, and small-molecule inhibitors targeting this pathway show potential for treating various inflammatory diseases and certain cancers.

Effective Combinatorial Immunotherapy for Castration Resistant Prostate Cancer

Combining immune checkpoint blockade with MDSC-targeted therapies shows robust synergistic responses in metastatic castration-resistant prostate cancer, potentially improving treatment outcomes.

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma

CXCR2 inhibition significantly slows pancreatic tumorigenesis and reduces metastasis, making it a promising therapeutic target in pancreatic cancer.

Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.

Novel CNS penetrant CXCR2 antagonists show potential as a therapeutic target for demyelinating diseases like multiple sclerosis, with compound 22 showing efficacy in a cuprizone-induced demyelination model.

Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling

Targeting CXCR1 with reparixin and paclitaxel effectively reduces breast cancer stem cell population and brain tumor metastasis, potentially benefiting advanced breast cancer patients.

Citations

Recent updates on the synthesis of thiazolopyrimidines derivatives

Synthetic approaches for thiazolopyrimidines derivatives, including thiazolo[3,2-a]pyrimidine, thiazolo[5,4-d]pyrimidine, and thiazolo[4,5-d]pyrimidine, have shown promising results in medicinal chemistry.

Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases

Targeting PDZ-dependent interactions with peptides could help control immune-related diseases by preventing viral replication and dissemination.

A review on synthetic procedures and applications of phosphorus oxychloride (POCl3) in the last biennial period (2018–19)

Phosphorus oxychloride (POCl3) has diverse applications in synthetic chemistry, including chlorination, Vilsmeier Haack reaction, dehydration, and cyclization, with recent applications in organic syntheses.

Targeting CXCR1/2: The medicinal potential as cancer immunotherapy agents, antagonists research highlights and challenges ahead.

CXCR1/2 antagonists show potential in cancer immunotherapy by targeting immune suppressive cells in the tumor microenvironment, but face challenges in clinical development and clinical trials.

Autocatalyzed three-component cyclization of polyfluoroalkyl-3-oxo esters, methyl ketones and alkyl amines: a novel approach to 3-alkylamino-5-hydroxy-5-polyfluoroalkylcyclohex-2-en-1-ones.

This one-pot reaction efficiently synthesizes 3-alkylamino-5-hydroxy-5-polyfluoroalkylcyclohex-2-en-1-ones, which show moderate antifungal activities against pathogenic fungal strains.

New multicomponent approach to polyfluoroalkylated pyrido[1,2-a]pyrimidine derivatives and bis-cyclohexenones

This study presents a new multicomponent approach for synthesizing polyfluoroalkylated pyrido[1,2-a]pyrimidine derivatives and bis-cyclohexenones, some of which show moderate antiviral activity against influenza A/Puerto Rico/8/34 (